AMCGX
Price
$9.00
Change
-$0.05 (-0.55%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

AMCGX vs RPTIX

Header iconAMCGX vs RPTIX Comparison
Open Charts AMCGX vs RPTIXBanner chart's image
Alger Mid Cap Growth B
Price$9.00
Change-$0.05 (-0.55%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AMCGX vs RPTIX Comparison Chart
Loading...
VS
AMCGX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMCGX is a Buy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. AMCGX (242M). RPTIX pays higher dividends than AMCGX: RPTIX (0.18) vs AMCGX (0.00). AMCGX was incepted earlier than RPTIX: AMCGX (31 years) vs RPTIX (9 years). AMCGX is a more actively managed with annual turnover of: 78.35 vs. RPTIX (21.70). AMCGX has a lower initial minimum investment than RPTIX: AMCGX (1000) vs RPTIX (500000). AMCGX annual gain was more profitable for investors over the last year : 25.00 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. AMCGX (-20.77).
AMCGXRPTIXAMCGX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years9 years-
Gain YTD12.9849.127142%
Front LoadN/AN/A-
Min. Initial Investment10005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets242M31.4B1%
Annual Yield % from dividends0.000.18-
Returns for 1 year25.0014.81169%
Returns for 3 years-48.74-13.57359%
Returns for 5 years-20.7715.09-138%
Returns for 10 years7.93N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp